{
  "id": 657821,
  "title": "Boulevard starts up with $65M to pursue targeted autoimmune drugs",
  "url": "https://urgent.news/2026/08/12/boulevard-starts-up-with-65m-to-pursue-targeted-autoimmune-drugs",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-12T10:30:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/boulevard-immune-drugs-igan-georg-schett/827583/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Co-founded by pioneering researcher Georg Schett and ex-Sanofi CSO Frank Nestle, the startup is advancing a trio of multifaceted antibodies with the potential to treat several immune diseases.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}